For adults with moderate to severe hidradenitis suppurativa
COSENTYX® (secukinumab) is proven to help people find relief from HS symptoms.
Hidradenitis suppurativa (HS) is a chronic, or long-lasting, inflammatory skin condition. It is thought that an overactive immune system may contribute to inflammation in different areas of the body that can lead to HS symptoms, like bumps and abscesses that can hurt. Living with HS can be a daily challenge.
See how COSENTYX helped Lily and NiYondashay
Actual patients were compensated for their time. Individual results may vary.
Real relief for people with HS
50% REDUCTION OF ABSCESSES & NO INCREASE IN THESE SYMPTOMS
In the 2 clinical trials, 41% and 43% of adults taking COSENTYX 300 mg every 4 weeks (after 5 initial weekly doses) had at least a 50% reduction in the number of inflammatory bumps and abscesses, with no increase in the number of abscesses and/or draining tunnels at 16 weeks vs 29% and 26% taking placebo.
ZERO FLARES AT 16 WEEKS FOR THE MAJORITY OF PEOPLE
In 1 of 2 clinical trials, 75% of adults taking COSENTYX had zero flares at week 16.† In the same clinical trial, 25% of adults taking COSENTYX had 1 or more flares at week 16 vs 36% taking placebo. In the second clinical trial, the same results were not seen. A flare was defined as a greater than 25% increase in the number of inflammatory bumps and abscesses, with a minimum increase of 2 inflammatory bumps or abscesses.
†COSENTYX 300 mg every 4 weeks (after 5 initial weekly doses).
Proven experience
The safety of COSENTYX is well studied — with 18 years of clinical testing‡.
‡Across all indications combined.
Learn more about the COSENTYX experience.
How is COSENTYX different?
COSENTYX targets and blocks IL-17A, an important molecule that contributes to inflammation that may lead to HS symptoms.
See how COSENTYX takes on HS—from the inside out. Watch a video of how COSENTYX is thought to help adults with HS.
Download our patient brochure to learn more about treating moderate to severe HS in adults with COSENTYX.
Savings & Support
Enroll in our Co-Pay offer and pay as little as $0* through the COSENTYX® Connect Co-Pay Program, if privately insured and otherwise eligible.
COSENTYX® Connect is a free, personalized support program for people taking or considering COSENTYX. Our goal is to make the COSENTYX experience as easy, affordable, and convenient as possible for you. Sign up now and you'll have access to a full range of services, like a dedicated COSENTYX® Connect Team, co-pay offer,* if eligible, and injection resources.
*Limitations apply. Subject to annual co-pay benefit limit. Offer not valid under Medicare, Medicaid, or any other federal or state programs. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions for details.